Oka Ryo, Li Bochong, Kato Seiji, Utsumi Takanobu, Endo Takumi, Kamiya Naoto, Nakaguchi Toshiya, Suzuki Hiroyoshi
Department of Urology, Toho University Sakura Medical Center, Sakura, Japan.
Department of Medical System Engineering, Graduate School of Engineering, Chiba University Center for Frontier Medical Engineering, Chiba University, Chiba, Japan.
Curr Urol. 2025 Sep;19(5):309-313. doi: 10.1097/CU9.0000000000000271. Epub 2025 Feb 3.
With the rising incidence of prostate cancer (PCa), there is a global demand for assistive tools that aid in the diagnosis of high-grade PCa. This study aimed to develop a diagnostic support system for high-grade PCa using innovative magnetic resonance imaging (MRI) sequences in conjunction with artificial intelligence (AI).
We examined image sequences of 254 patients with PCa obtained from diffusion-weighted and T2-weighted imaging, using novel MRI sequences before prostatectomy, to elucidate the characteristics of the 3-dimensional (3D) image sequences. The presence of PCa was determined based on the final diagnosis derived from pathological results after prostatectomy. A 3D deep convolutional neural network (3DCNN) was used as the AI for image recognition. Data augmentation was conducted to enhance the image dataset. High-grade PCa was defined as Gleason grade group 4 or higher.
We developed a learning system using a 3DCNN as a diagnostic support system for high-grade PCa. The sensitivity and area under the curve values were 85% and 0.82, respectively.
The 3DCNN-based AI diagnostic support system, developed in this study using innovative 3D multiparametric MRI sequences, has the potential to assist in identifying patients at a higher risk of pretreatment of high-grade PCa.
随着前列腺癌(PCa)发病率的上升,全球对有助于诊断高级别PCa的辅助工具存在需求。本研究旨在结合创新的磁共振成像(MRI)序列和人工智能(AI)开发一种用于高级别PCa的诊断支持系统。
我们检查了254例PCa患者在前列腺切除术前使用新型MRI序列从扩散加权成像和T2加权成像获得的图像序列,以阐明三维(3D)图像序列的特征。PCa的存在根据前列腺切除术后病理结果得出的最终诊断来确定。使用三维深度卷积神经网络(3DCNN)作为图像识别的人工智能。进行数据增强以增加图像数据集。高级别PCa定义为Gleason分级组4或更高。
我们开发了一个使用3DCNN作为高级别PCa诊断支持系统的学习系统。灵敏度和曲线下面积值分别为85%和0.82。
本研究使用创新的3D多参数MRI序列开发的基于3DCNN的人工智能诊断支持系统,有可能帮助识别高级别PCa预处理风险较高的患者。